As the biologics and biosimilars market continues to grow, questions emerge about what to do at the pharmacy counter. Audit expert Trent Thiede, PharmD, MBA, president, PAAS National, will be at the 2024 Multiple Locations Conference to discuss biosimilars, interchangeability, and appropriate DAW codes. Find out what you need to know about this space, including the clinical, operational, and financial considerations for biosimilar utilization and how to avoid audits in his session, “How Biosimilars Are Changing the Way You Practice.” So, join us at the Marriott Sanibel Harbour Resort and Spa (Feb. 28 – March 2) by registering now.
NCPA
